New Class of Drugs Kills MRSA in Mice

Researchers find two new antibiotics that offer promise in the fight against drug-resistant bacteria.

Written byJim Daley
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Methicillin-resistant Staphylococcus aureus (MRSA) bacteriaFLICKR, NIAID

Scientists have discovered a new class of antibiotics that can kill methicillin-resistant Staphylococcus aureus (MRSA) in mice. The drugs, called synthetic retinoid antibiotics, are in the same family of compounds as Vitamin A. In the study, published yesterday (March 28) in Nature, the researchers modified the retinoids to maintain their ability to attack MRSA while minimizing their toxicity.

“The molecule weakens the cell membranes of bacteria, but human cells also have membranes,” study coauthor William Wuest, a chemist at Emory University, says in a statement. “We found a way to tweak the molecule so that it now selectively targets bacteria.”

Under the looming crisis of antibiotic resistance and evolution of “superbugs” that are multidrug resistant, the task of finding new classes of compounds that can ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies